Long Term Mortality of Patients with Non-alcoholic Fatty Liver Disease (NAFLD)

被引:0
|
作者
Golabi, Pegah [1 ]
Otgonsuren, Munkhzul [1 ]
Arsalla, Aimal [2 ]
Erario, Madeline [1 ]
Srishord, Manirath [1 ]
Younossi, Zobair M. [1 ,2 ]
机构
[1] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
[2] Inova Fairfax Hosp, Dept Med, Ctr Liver Dis, Falls Church, VA USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1050
引用
收藏
页码:529A / 530A
页数:2
相关论文
共 50 条
  • [1] Non-alcoholic fatty liver disease (NAFLD) and mortality
    Ruhl, Constance E.
    Everhart, James E.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 51 (03) : 593 - 593
  • [2] Long-Term Outcomes of Diabetic Patients with Non-alcoholic Fatty Liver Disease (NAFLD)
    Golabi, Pegah
    Shahab, Omer
    Stepanova, Maria
    Sayiner, Mehmet
    Clement, Stephen C.
    Younossi, Zobair M.
    [J]. HEPATOLOGY, 2017, 66 : 1142A - 1143A
  • [3] Non-alcoholic fatty liver disease (NAFLD)
    Rau, Monika
    Weiss, Johannes
    Geier, Andreas
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (14) : 1051 - +
  • [4] Is the Risk of Mortality increased in Lean Patients in Non-alcoholic Fatty Liver Disease (NAFLD)?
    Younossi, Zobair M.
    Otgonsuren, Munkhzul
    Keo, Wisna'odom
    Gogoll, Trevor
    Arsalla, Aimal
    Badoe, Nina
    Ford, Joel S.
    Mann, Puneetinder
    Cooper, James N.
    Racila, Andrei
    [J]. HEPATOLOGY, 2016, 64 : 107A - 107A
  • [5] Presumed Non-alcoholic Steatofibrosis Can Independently Predict Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
    Younossi, Zobair M.
    Stepanova, Maria
    Golabi, Pegah
    Pham, Huong T.
    Cable, Rebecca
    Cooper, James N.
    Rafiq, Nila
    Bush, Haley
    Mann, Puneetinder
    Gogoll, Trevor
    [J]. HEPATOLOGY, 2017, 66 : 1143A - 1143A
  • [6] Long term outcomes of non-alcoholic fatty liver disease (NAFLD) and metabolic associated fatty liver disease (MAFLD)
    Younossi, Zobair
    Paik, James
    Younossi, Issah
    Golabi, Pegah
    Harring, Michael
    Henry, Linda
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S155 - S156
  • [7] Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD)
    Golabi, Pegah
    Stepanova, Maria
    Pham, Huong T.
    Cable, Rebecca
    Rafiq, Nila
    Bush, Haley
    Gogoll, Trevor
    Younossi, Zobair M.
    [J]. BMJ OPEN GASTROENTEROLOGY, 2018, 5 (01):
  • [8] Non-alcoholic steatofibrosis is independently associated with both overall mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD)
    Younossi, Z. M.
    Stepanova, M.
    Rafiq, N.
    Golabi, P.
    de Avila, L.
    Monge, F.
    Goodman, Z.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S598 - S598
  • [9] Non-alcoholic fatty liver disease (NAFLD). Non-alcoholic steatohepatitis - NASH
    Keller, KM
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 2004, 152 (08) : 864 - 869
  • [10] In Patients with Non-alcoholic Fatty Liver Disease (NAFLD), Metabolic Conditions are Independently Associated with Mortality
    Younossi, Zobair M.
    Otgonsuren, Munkhzul
    Locklear, Cameron T.
    Venkatesan, Chapy
    Mishra, Alita
    Erario, Madeline
    Srishord, Manirath
    Racila, Andrei
    Arsalla, Aimal
    Kalwaney, Shirley K.
    [J]. HEPATOLOGY, 2015, 62 : 495A - 495A